Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

GnRH treatment can reduce breast cancer cell invasion.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Analog 23 is a promising compound for prostate cancer treatment.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

CDPDFM can improve acne symptoms in rabbit ears.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Cow colostrum and milk can effectively produce anti-hair keratin antibodies.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

UDCA reduces inflammation and joint damage in rheumatoid arthritis.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Calancardin B may help reduce inflammation in immune cells.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.